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ndoplasmic reticulum (ER) stress has been implicated in
the pathogenesis of ischemic and neurodegenerative
disorders. Treatment of human SH-SY5Y neuroblastoma
cells with tunicamycin, an inhibitor of protein glycosylation,
rapidly induced the expression of target genes of the unfolded
protein response. However, prolonged treatment also trig-
gered a delayed, caspase-dependent cell death. Microarray
analysis of gene expression changes during tunicamycin-
induced apoptosis revealed that the Bcl-2 homology domain
3-only family member, Bcl-2 binding component 3/p53
upregulated modulator of apoptosis (
 
Bbc3/PUMA
 
), was the
most strongly induced pro-apoptotic gene. Expression of
E
 
Bbc3/PUMA correlated with a Bcl-xL–sensitive release of
cytochrome 
 
c
 
 and the activation of caspase-9 and -3. In-
creased expression of Bbc3/PUMA was also observed in
p53-deﬁcient human cells, in response to the ER stressor
thapsigargin, and in rat hippocampal neurons after transient
forebrain ischemia. Overexpression of Bbc3/PUMA was
sufﬁcient to trigger apoptosis in SH-SY5Y neuroblastoma
cells, and human cells deﬁcient in 
 
Bbc3/PUMA
 
 showed
dramatically reduced apoptosis in response to ER stress. Our
data suggest that the transcriptional induction of Bbc3/
PUMA may be sufﬁcient and necessary for ER stress–induced
apoptosis.
 
Introduction
 
An imbalance between the cellular demand for protein syn-
thesis and the capacity of the ER in promoting protein
maturation and transport can lead to an accumulation of
unfolded or malfolded proteins in the ER lumen. This con-
dition has been designated “ER stress” (Kaufman, 1999). It
has been suggested that ER stress contributes to neuronal
injury after cerebral ischemia (Paschen and Frandsen, 2001;
DeGracia et al., 2002) and may play an important role in
the pathogenesis of neurodegenerative disorders such as
Parkinson’s and Alzheimer’s disease (Sherman and Goldberg,
2001).
ER stress provokes a controlled transcriptional response,
the unfolded protein response (UPR). Target genes of the
UPR include molecular chaperones that help to alleviate ER
stress by promoting the correct folding of nascent proteins
in the ER and by inhibiting the aggregation of aberrant pro-
teins. However, if ER stress is severe and prolonged, stressed
cells will eventually activate an evolutionary conserved, cas-
pase-dependent death program (Perez-Sala and Mollinedo,
1995). In murine cells, ER stress–induced cell death has
been shown to involve the activation of ER-resident caspase-12,
which subsequently activates executioner caspases such as
caspase-3 (Nakagawa and Yuan, 2000; Nakagawa et al.,
2000). However, although the role of caspase-12 in ER
stress–induced apoptosis of murine cells is well established,
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there is also evidence that the human caspase-12 gene is
nonfunctional due to the acquisition of inactivating gene
mutations (Fischer et al., 2002). This suggests that addi-
tional pathways may be important in humans.
Indeed, evidence has been presented that ER stress may
activate the mitochondrial apoptosis pathway (Häcki et al.,
2000; Annis et al., 2001; Wei et al., 2001). In this path-
way, the release of pro-apoptotic factors from mitochon-
dria requires an increase in outer mitochondrial membrane
permeability, triggered by the pro-apoptotic Bcl-2 family
members Bax and Bak (Desagher and Martinou, 2000;
Wei et al., 2001). Both proteins have to undergo a confor-
mational change to trigger this increase. In healthy cells,
anti-apoptotic Bcl-2 family members such as Bcl-2 and
Bcl-xL inhibit this conformational change. On induction
of apoptosis, this inhibition is overcome by the transcrip-
tional induction or posttranslational activation of Bcl-2 ho-
mology domain 3 (BH3)-only proteins (Huang and Strasser,
2000).
In the present work, we used high density oligonucleotide
microarrays to analyze gene expression during tunicamycin-
induced ER stress in human neural cells, and provide evi-
dence that the transcriptional induction of the BH3-only
protein Bcl-2 binding component 3/p53 upregulated modu-
lator of apoptosis (Bbc3/PUMA) activates the mitochondrial
apoptosis pathway in response to ER stress.
 
Results
 
Tunicamycin induces caspase-dependent apoptosis 
in neurons
 
Treatment of human SH-SY5Y neuroblastoma cells with the
ER stressor tunicamycin induced mRNA and protein ex-
pression of the ER resident molecular chaperone immuno-
Figure 1. Tunicamycin induces ER 
stress and apoptosis in human SH-SY5Y 
neuroblastoma cells and rat hippocampal 
neurons. (A and B) Induction of BiP by 
tunicamycin treatment of SH-SY5Y cells. 
(A) Kinetics of BiP mRNA induction by 
tunicamycin in SH-SY5Y cells. Cells were 
treated with 3  M tunicamycin or vehicle 
(DMSO) for the indicated times. Total 
RNA was analyzed by RT-PCR analysis 
for the expression of BiP and GAPDH. 
(B) Kinetics of BiP protein expression after 
tunicamycin treatment of SH-SY5Y cells. 
Whole-cell extracts were analyzed by 
Western blot analysis for BiP and 
 -tubulin protein levels. Similar results 
were obtained in two independent experi-
ments. (C) Flow cytometric analysis of 
DNA fragmentation induced by tunica-
mycin. SH-SY5Y cells were incubated for 
24 h with 3  M tunicamycin or vehicle 
with or without addition of 200  M 
zVAD-fmk. After treatment, cells were 
harvested, permeabilized, and stained 
with propidium iodide (FL2-H). Subse-
quently, cells were analyzed by FACS
®. 
The sub-G1 region is marked with M1. 
Data from 10,000 cells are shown. (D) 
Time course of appearance of sub-G1 
cells. The percentage of events within 
the marked region (M1), which repre-
sents the apoptotic cell population, was 
calculated using CellQuest™ software 
(BD Biosciences). Data are means   
SEM from n   4 separate experiments per 
time point. Different from control (Con): 
*, P   0.05. (E) Time course of tunicamy-
cin-induced caspase-3–like protease ac-
tivity in SH-SY5Y neuroblastoma cells. 
Caspase-3–like activity was measured by 
cleavage of 10  M fluorogenic substrate 
Ac-DEVD-AMC. Data are means   SEM 
from n   3 separate experiments. Different from control (Con): *, P   0.05. (F) Tunicamycin treatment of rat hippocampal neurons leads to the 
apoptotic phenotype with condensed and fragmented nuclei. Cultures of primary hippocampal neurons were incubated with 3  M tunicamycin 
or vehicle for 24 h. Cells were fixed and nuclei were stained with Hoechst 33258. Bar, 25  m. (G) Quantification of apoptosis in tunicamycin-
treated hippocampal neurons. Cultures were incubated with the indicated concentrations of tunicamycin for 24 h. Cells were fixed and stained 
with Hoechst 33258. Apoptotic nuclei, showing condensed or fragmented chromatin, were counted within three randomly chosen subfields. 
Data are means   SEM from n   4–12 cultures in three separate experiments. Different from control (Con): *, P   0.05.T
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globulin heavy chain–binding protein (
 
BiP
 
), a known UPR
target gene (Fig. 1, A and B). Despite this protective re-
sponse, prolonged treatment with tunicamycin resulted in
apoptotic cell death. FACS
 
®
 
 analysis of the DNA content
demonstrated that tunicamycin treatment induced a charac-
teristic sub-G1 peak in the human neuroblastoma cells, in-
dicative of DNA fragmentation, a hallmark of apoptosis
(Fig. 1 C). After 24 h, 
 
 
 
50% of cells had a reduced DNA
content (Fig. 1 D, sub-G1). Co-incubation with the broad-
spectrum caspase inhibitor zVAD-fmk blocked the ap-
pearance of sub-G1 cells, indicating that this process was
caspase-dependent. Indeed, tunicamycin induced a caspase-
 
Table I. 
 
Differentially expressed genes after tunicamycin treatment classified into distinct functional subgroups
Target genes GenBank/EMBL/DDBJ 
accession no.
Up-/down-
regulated
Course
Protein folding and maturation
 
BiP/GRP78  X87949
 
 
 
Persistent
Protein disulfide-isomerase–related protein P5 D49489
 
 
 
Persistent
Collagen-binding protein 2 D83174
 
 
 
Persistent
Fourth mammalian ER DNAJ protein (ERdj4) AL080081
 
 
 
Early
Oxygen-regulated protein 150 kD (ORP150) U65785
 
 
 
Late
FK506-binding protein (FKBP13) AA158243
 
 
 
Late
GRP94 X15187
 
 
 
Late
Protein disulfide-isomerase ERp70-like AI262789
 
 
 
Late
Protein disulfide-isomerase ERp60 Z49835
 
 
 
Late
Proline 4-hydroxylase, beta subunit (P4HB) J02783
 
 
 
Intermediate
hsc70 (71-kD heat shock cognate protein)  Y00371
 
 
 
Intermediate
 
Protein transport
 
Putative mitochondrial inner membrane protein import receptor (hTIM44) AF026030
 
 
 
Persistent
Translocon-associated protein delta subunit (TRAP 
 
 
 
) Z69043
 
 
 
Late
Syntaxin 5 U26648
 
 
 
Late
Translocating chain–associating membrane protein (TRAM) X63679
 
 
 
Late
Transmembrane protein rnp24 X92098
 
 
 
Late
 
Protein synthesis and modification
 
Glycyl-tRNA synthetase U09510
 
 
 
Persistent
Alanyl-tRNA synthetase D32050
 
 
 
Persistent
Asparagine synthetase M27396
 
 
 
Persistent
Glutamine-fructose-6-phosphate amidotransferase (GFAT) M90516
 
 
 
Intermediate
Integral membrane protein 1 (ITM1) L38961
 
 
 
Late
 
Ca
 
2+
 
 homeostasis
 
Calreticulin AD000092
 
 
 
Persistent
Stanniocalcin 2 AF098462
 
 
 
Early
Plasma membrane Ca
 
2+
 
-pumping ATPase J04027
 
 
 
Intermediate
Calnexin L10284
 
 
 
Late
Novel DNA-binding/EF-hand/leucine zipper protein (NEFA) X76732
 
 
 
Late
Nucleobindin 1 M96824
 
 
 
Late
 
Transcription factors
 
CHOP S62138
 
 
 
Persistent
C/EBP-beta X52560
 
 
 
Persistent
TGF-
 
 
 
–stimulated clone 22 (TSC22)-like AI635895
 
 
 
Persistent
X-box–binding protein 1 (XBP-1) Z93930
 
 
 
Early
Egr-1 X52541
 
 
 
Early
 
UPR target genes of unknown function
 
HERP AF055001
 
 
 
Persistent
SERP/RAMP4 AI557272
 
 
 
Late
 
Apoptosis
 
Bbc3/PUMA U82987
 
 
 
Intermediate
Expression profiling by microarray analysis after induction of ER stress with tunicamycin. SH-SY5Y neuroblastoma cells were treated with 3 
 
 
 
M tunicamycin
for 4, 8, or 12 h. Controls were treated with vehicle (DMSO) for 8 h. cRNA was prepared and hybridized to HG-U95A microarrays, after which relative
mRNA levels were quantified with the Affymetrix Microarray Suite 4.1 software (see Materials and methods). GRP78, 78-kD glucose-regulated protein;
GRP94, 94-kD glucose-regulated protein; HERP, homocysteine-inducible, ER stress–inducible, ubiquitin-like domain member 1; SERP1/RAMP4, stress-
associated ER protein 1/ribosome-associated membrane protein 4; C/EBP-beta, CCAAT/enhancer-binding protein beta. Column 4 (Course) refers to the
expression kinetics shown in Fig. 2 A.T
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3–like protease activity in cytosolic extracts determined by
measuring the cleavage of Ac-DEVD-AMC, a fluorogenic
substrate preferentially cleaved by caspase-3 and -7 (Fig. 1
E). Treatment with tunicamycin also induced apoptosis in
primary cultures of rat hippocampal neurons (Fig. 1 F)
reaching a maximum at a concentration of 10–30 
 
 
 
M (Fig.
1 G). Treatment with tunicamycin also led to an early in-
duction of the molecular chaperone BiP in the hippocampal
neuron cultures (unpublished data).
 
Gene expression microarray analysis of 
tunicamycin-treated SH-SY5Y cells
 
We used high density oligonucleotide microarrays to analyze
gene expression changes during tunicamycin-induced cell
death. RNA was isolated from SH-SY5Y neuroblastoma
cells treated for 4, 8, or 12 h with 3 
 
 
 
M tunicamycin. A to-
tal of 138, 225, and 151 genes were found to be up-regu-
lated after 4, 8, and 12 h of tunicamycin treatment, respec-
tively (see Materials and methods for detailed description of
data analysis). The number of down-regulated genes was
100, 69, and 88 after 4, 8, and 12 h, respectively. Table I
provides a list of selected, differentially expressed genes after
ER stress, sorted into distinct functional subgroups. Column
4 refers to the expression kinetics shown in Fig. 2 A. Expres-
sion kinetics were classified into persistent, early, interme-
diate, or late changes (Fig. 2 A). Increased expression of
distinct ER stress–induced genes was confirmed by semi-
quantitative RT-PCR analysis (Fig. 2 B). A list of all differ-
entially expressed genes is provided in the supplemental
material (available at http://www.jcb.org/cgi/content/full/
jcb.200305149/DC1).
 
Genes involved in protein folding
 
The largest group of up-regulated target genes was repre-
sented by ER-resident molecular chaperones and disulfide
isomerases. Among the molecular chaperones, we found es-
 
tablished UPR target genes such as 
 
BiP
 
, 94-kD glucose-reg-
ulated protein, oxygen-regulated protein 150 (
 
ORP150
 
),
and the fourth mammalian ER DNAJ protein (
 
ERdj4
 
).
Other activated genes included disulfide isomerases such as
protein disulfide isomerase ER-60 precursor (
 
ERp60
 
) and
the proline 4-hydroxylase, 
 
 
 
 subunit (
 
P4HB
 
). Protein fold-
ing is catalyzed and accelerated by members of the peptidyl
prolyl cis/trans isomerase family of which 
 
cyclophilin B
 
 and
FK506-binding protein 13 (
 
FKBP13
 
) were potently up-reg-
ulated by tunicamycin. Interestingly, the expression of the
chaperone 71-kD heat shock cognate protein (
 
hsc70
 
) was
significantly lowered during ER stress. Other chaperones
down-regulated on tunicamycin treatment included DNAJ-
like 2, the 90-kD heat shock protein, and the 28-kD heat
shock protein.
 
Genes involved in protein transport
 
The second major group of target genes included genes in-
volved in cotranslational translocation of proteins across the
ER membrane and the anterograde/retrograde transport back
into the cytosol. This group included the signal recognition
particle receptors 
 
SRP54
 
 and 
 
SRP19
 
, the signal sequence re-
ceptors 
 
SSR1
 
 and 
 
4
 
, members of the SEC61 complex (
 
SEC61
 
 
 
 and 
 
 
 
, as well as 
 
SEC63
 
), translocating chain–associating
membrane protein (
 
TRAM
 
) and translocon-associated pro-
tein delta subunit (
 
TRAP 
 
 
 
). Up-regulated genes also in-
cluded genes involved in the anterograde/retrograde transport
between ER and Golgi. These were represented by a coated
vesicle membrane protein (
 
rnp24
 
), a transmembrane traffick-
ing protein (
 
tmp21
 
), and 
 
syntaxin 5
 
. Other up-regulated genes
involved in intracellular protein trafficking included the mito-
chondrial inner membrane translocase 
 
hTIM44
 
.
 
Genes involved in protein synthesis
 
The translational machinery for a new boost of protein syn-
thesis has been suggested to be amplified during UPR-asso-
Figure 2. Selected tunicamycin-induced genes classified with respect to their expression kinetics. Expression profiling by microarray 
analysis after induction of ER stress was performed as described in the legend of Table I. (A) Four representative genes per group were 
chosen. (B) Confirmation of gene chip data by semiquantitative RT-PCR analysis of five selected genes. GAPDH served as control. Similar 
results were obtained in two separate experiments. HERP, homocysteine-inducible, ER stress-inducible, ubiquitin-like domain member 1; 
STC2, stanniocalcin 2; BRD3, bromodomain containing protein 3; MAP1B, microtubule-associated protein 1B; HSRPTK, homo sapiens 
receptor protein tyrosine kinase; DYRK4, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4; FKBP13, 13-kD FK506-binding 
protein; DOC1R, deleted in oral cancer-related 1; hTIM44, putative mitochondrial inner membrane protein import receptor; P4HB, proline 
4-hydroxylase, beta subunit; NEFA, novel DNA-binding/EF-hand/leucine zipper protein; TRAM, translocating chain-associating membrane 
protein; XBP-1, X-box–binding protein 1.T
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ciated translational attenuation (Okada et al., 2002). We ob-
served an up-regulation of eight tRNA synthetase genes after
treatment with tunicamycin. Asparagine synthetase, an acti-
vating transcription factor 4 (ATF4) target gene, was also
significantly induced.
Genes regulating Ca
2  homeostasis
Members of this group included calreticulin and calnexin.
Both proteins regulate ER Ca
2  homeostasis, but also func-
tion as Ca
2 -dependent ER chaperones. Genes involved in
the regulation of Golgi Ca
2  homeostasis included nucleo-
bindin 1 and novel DNA binding/EF-hand/leucine zipper
protein (NEFA). Of note, two members of the P-type trans-
port ATPase family, the plasma membrane Ca
2  pumping
ATPase (ATP2B1) and sarcoplasmic reticulum Ca
2 -ATPase
2 (ATP2A2) were also induced.
Transcription factors
Up-regulated transcription factors included two established
UPR target genes: C/EBP homologous protein (CHOP) and
X box–binding protein 1 (XBP-1). Both transcription fac-
tors were persistently activated with a relatively even expres-
sion level at all three time points investigated. CHOP
showed the largest expression increase of all genes analyzed.
Interestingly, expression of the stress-responsive transcrip-
tional regulator early growth response 1 (Egr-1) was also sig-
nificantly enhanced. In addition, the CHOP interaction
partner CCAAT/enhancer binding protein beta (C/EBP- )
was potently induced.
ER stress induced by tunicamycin activates the 
BH3-only gene bbc3/PUMA
Tunicamycin-induced ER stress also altered the transcrip-
tion of bbc3/PUMA, a member of the BH3-only gene fam-
ily. Microarray analysis could not detect an altered tran-
scription of other Bcl-2 family members, including the
BH-3-only genes bim, bad, and ATL-derived PMA-respon-
sive peptide (APR; human Noxa), the pro-apoptotic Bcl-2
family members bax and bak, and the anti-apoptotic genes
bcl-2 and bcl-x. There was a mild induction of DR5/Trail-R2
(2.1-fold increase after 8 h), but the expression of other
genes involved in death receptor–mediated apoptosis includ-
ing Fas/CD95/APO-1, Fas ligand, TRAIL, and TRAIL-
Receptor DR3, was not found to be altered.
Northern blot analysis demonstrated that up-regulation of
bbc3/PUMA expression could be observed 4 h after addition of
tunicamycin (Fig. 3 A). Cell lysates of SH-SY5Y cells treated
with 3  M tunicamycin showed elevated Bbc3/PUMA pro-
tein levels starting 12 h after onset of treatment (Fig. 3 B, top).
Parallel analysis of caspase-3 activation revealed an ensuing ap-
pearance of active caspase-3 subunits detected with an anti-
body predominantly recognizing the p20 subunit (Fig. 3 B,
middle). In concordance with the microarray data, we failed to
detect significant protein induction of Bim and Bid (Fig. 3 C),
two BH3-only proteins previously implicated in stress-induced
apoptosis (Bouillet et al., 1999; Plesnila et al., 2001; Putcha et
al., 2001; Whitfield et al., 2001).
Figure 3. ER stress induces enhanced Bbc3/PUMA mRNA and 
protein levels. (A) Expression of bbc3/PUMA mRNA during 
tunicamycin-induced ER stress in SH-SY5Y neuroblastoma cells 
determined by Northern blot analysis. (B) Kinetics of Bbc3/PUMA 
protein expression and caspase-3 activation during tunicamycin-
induced cell death in SH-SY5Y neuroblastoma cells. Whole-cell 
extracts of cells treated for the indicated times with 3  M tunicamycin 
or vehicle (DMSO) were analyzed by Western blot analysis. 
Membranes were probed for either Bbc3/PUMA expression levels 
or caspase-3 activation. Arrowheads indicate active caspase-3 
subunits (p20, p17, and p14).  -Tubulin served as a loading control. 
Similar results were obtained in two separate experiments. (C) Bim 
and Bid protein expression during tunicamycin-induced cell death in 
SH-SY5Y neuroblastoma cells. Cells were treated as described above.
Figure 4. ER stress is able to induce bbc3/PUMA in a p53-
independent manner. (A) Tunicamycin treatment does not lead to 
an accumulation of p53 and p21 in SH-SY5Y cells. p53 and p21 
protein levels after exposure to tunicamycin (TU; 3  M, 24 h), 
etoposide (ETO; 50  M, 24 h), or vehicle (controls; DMSO, 24 h) 
were evaluated by Western blotting. (B and C) Kinetics of ER 
stress–induced bbc3/PUMA mRNA and protein levels after 3  M 
tunicamycin treatment in p53-deficient human SAOS-2 osteosarcoma 
cells determined by Northern and Western blot analyses.T
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Induction of Bbc3/PUMA is a general, p53-independent 
cellular response to prolonged ER stress
bbc3/PUMA has been described as a p53 target gene (Han et
al., 2001; Nakano and Vousden, 2001; Yu et al., 2001).
However, the microarray data did not reveal significant in-
duction of classical p53 target genes such as p21 and human
mdm2. Although Western blot analysis demonstrated signif-
icant p53 accumulation and p21 protein induction in SH-
SY5Y cells treated with the topoisomerase II inhibitor etopo-
side, tunicamycin treatment had no effect on p53 and p21
protein levels (Fig. 4 A). Moreover, tunicamycin increased
bbc3/PUMA mRNA and protein levels in p53-deficient hu-
man SAOS-2 osteosarcoma cells (Fig. 4, B and C).
bbc3/PUMA mRNA (Fig. 5 A) and protein (unpublished
data) levels also increased in SH-SY5Y neuroblastoma cells
exposed to the ER Ca
2  ATPase inhibitor thapsigargin,
demonstrating that the activation of bbc3/PUMA was ob-
served after treatment with a second, pharmacologically dis-
tinct ER stressor. Tunicamycin also increased the expression
of Bbc3/PUMA in cultured rat hippocampal neurons (Fig. 5
B), demonstrating that the activation of bbc3/PUMA was
not restricted to transformed human cells.
Cerebral ischemia is a pathophysiological ER stressor
(Paschen and Frandsen, 2001; DeGracia et al., 2002). In
male Wistar rats subjected to 10 min of forebrain ischemia,
increased nuclear accumulation of the transcription factor
CHOP could be detected in hippocampal pyramidal neu-
rons of the CA1 subfield as early as 1 h after ischemia (Fig.
5 C, top), indicating that ischemia/reperfusion injury in-
duced a rapid ER stress response in selectively vulnerable
brain regions. Expression of Bbc3/PUMA was not detect-
able during the first 24 h after transient forebrain ischemia,
but increased expression of CHOP could still be observed
(unpublished data). However, expression of Bbc3/PUMA
increased significantly in CA1 neurons 48–120 h after
ischemia (Fig. 5 C, bottom). This correlated with the onset
of neuronal degeneration (Fig. 5 C) and the occurrence of
TUNEL-positive nuclei in the CA1 hippocampal pyramidal
cells (Rami et al., 2000). Western blot analysis of the hippo-
campus and neocortex tissue of ischemic and sham-operated
animals 72 h after surgery also provided evidence for a sig-
nificant induction of Bbc3/PUMA expression in the selec-
tively vulnerable hippocampus (Fig. 5 D).
Activation of the mitochondrial apoptotic pathway 
during tunicamycin-induced apoptosis
Activation of bbc3/PUMA suggested that the mitochondrial
apoptosis pathway was activated during ER stress–induced
apoptosis. Indeed, treatment with tunicamycin led to Bax
activation and clustering in SH-SY5Y neuroblastoma cells,
as demonstrated by immunofluorescence analysis using an
antibody that specifically detects a conformational change in
the Bax protein required for its pro-apoptotic activity (Fig. 6
A). Cells exhibiting Bax clustering showed apoptotic mor-
phology and increased chromatin condensation. Cells with
increased chromatin condensation also lost their typical fila-
mentous cytochrome c staining (Fig. 6 B), indicating that
cytochrome c was released from mitochondria. Of note, the
apoptotic phenotype of SH-SY5Y cells was always associated
with markedly enhanced Bbc3/PUMA immunostaining.
Tunicamycin treatment also led to activation of caspase-9,
the apical caspase in the mitochondrial apoptosis pathway
(Fig. 6 C).
Subsequently, we investigated the effect of Bcl-xL overex-
pression on tunicamycin-induced apoptosis using SH-Neo
and SH-Bcl-xL cells (Luetjens et al., 2001). SH-Neo and
SH-Bcl-xL cells responded with increased expression of
Bbc3/PUMA and BiP to an exposure to 3  M tunicamycin
(Fig. 6 D; unpublished data). Selective digitonization of the
plasma membrane and subsequent immunoblotting experi-
ments revealed that tunicamycin induced a significant accu-
mulation of cytochrome c in the cytosol in SH-Neo cells
(Fig. 6 E). 3  M staurosporine (STS) also induced a promi-
Figure 5. Induction of Bbc3/PUMA is 
a general cellular response to prolonged 
ER stress. (A) Induction of bb33/PUMA 
mRNA in human SH-SY5Y neuroblastoma 
cells in response to thapsigargin (TH; 
1  M). Controls (Con) were treated with 
vehicle (DMSO, 24 h). (B) Bbc3/PUMA 
protein is expressed in primary hippo-
campal neurons after tunicamycin 
treatment. Cultures were treated for 24 h 
with 3  M tunicamycin or vehicle. An 
unspecific band of  24 kD served as 
loading control. (C) Top, increased 
expression of the ER stress–specific 
transcription factor CHOP detected by 
immunohistochemistry in the selective 
vulnerable CA1 hippocampal subfield 
of rats subjected to transient forebrain 
ischemia (Isch). Increased expression of 
CHOP was detectable as early as 1 h 
postischemia. Bottom, expression of Bbc3/PUMA is increased in dying CA1 hippocampal pyramidal neurons 5 d after transient forebrain 
ischemia. Sham-operated animals served as respective controls. Bar, 25  m. (D) Western blot analysis of Bbc3/PUMA expression in hippocampus 
and neocortex tissue homogenates 72 h after transient forebrain ischemia (Isch) or sham surgery (Con). Similar results were obtained in a 
second experiment.T
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nent release of cytochrome c into the cytosol of SH-Neo
cells. This release was more pronounced than the release
triggered by tunicamycin. However, in direct comparison
with tunicamycin, exposure to STS also led to a more rapid
and extensive cell death ( 80% cell death after 18 h;
Luetjens et al., 2001). Interestingly, both tunicamycin- and
STS-induced release of cytochrome c release could not be
observed in cells overexpressing Bcl-xL. Overexpression of
Bcl-xL also potently inhibited the activation of caspase-3–
like proteases (DEVDases) in response to tunicamycin and
STS (Fig. 6 F).
Expression of bbc3/PUMA may be sufficient 
and required for ER stress–induced apoptosis 
in human cells
To test whether expression of bbc3/PUMA was sufficient
to kill human SH-SY5Y neuroblastoma cells, cells were co-
transfected with a plasmid encoding EGFP (pEGFP) and
either hemagglutinin (HA)-tagged Bbc3/PUMA (pHA-
Bbc3/PUMA) or empty vector (pcDNA3.1). Hoechst 33258
staining and morphological analysis of GFP-positive cells
demonstrated that bbc3/PUMA-transfected cells revealed
morphological characteristics of apoptosis, including cell
Figure 6. Tunicamycin activates the mitochondrial apoptosis pathway. (A) Tunicamycin (TU) treatment activates Bax and induces 
chromatin condensation. Human SH-SY5Y neuroblastoma cells were exposed to 3  M tunicamycin or vehicle (Con) for 24 h. Distribution 
of active Bax and nuclear staining with Hoechst 33258 was analyzed by immunofluorescence microscopy. Bar, 25  m. (B) High level 
Bbc3/PUMA expression correlated with cytochrome c release in tunicamycin-treated SH-SY5Y cells. Cells were exposed to DMSO (Con) 
or 3  M tunicamycin (TU) for 24 h. Immunofluorescence analysis of Bbc3/PUMA expression and cytochrome c (CytC) redistribution, as 
well as nuclear staining with Hoechst 33258 was analyzed by epifluorescence microscopy. Arrows indicate cells that have a high expression 
level of Bbc3/PUMA, a diffuse cytochrome c fluorescence signal indicative of mitochondrial cytochrome c release, and condensed and 
fragmented chromatin. Bar, 50  m. (C) Kinetics of caspase-9 activation after tunicamycin-induced apoptosis in SH-SY5Y cells. Whole-cell 
extracts of cells treated for the indicated times with 3  M tunicamycin or 24 h with DMSO (Con), were analyzed by Western blotting. 
Activation of caspase-9 was performed with a rabbit pAb recognizing the 37-kD active subunit. An unspecific band of  40 kD serves as a 
loading control. (D) Induction of Bbc3/PUMA protein expression after tunicamycin treatment is not inhibited in cells overexpressing Bcl-xL. 
Cell lysates of SH-Bcl-xL cells, incubated with 3  M tunicamycin for the indicated times or for 24 h with the vehicle (Con) were subjected 
to Western blot analysis. Bcl-xL expression level served as loading control (bottom). Similar results were obtained in a separate experiment. 
(E) Tunicamycin induces cytochrome c release in SH-SY5Y cells, which is inhibitable by overexpression of Bcl-xL. SH-SY5Y cells stably 
transfected with an empty vector (SH-neo) or Bcl-xL (SH-Bcl-xL) were incubated for 24 h with vehicle (Con), 3  M tunicamycin (TU), or 
for 6 h with 3  M of the kinase inhibitor staurosporine (STS). Subsequently cells were subjected to controlled digitonin permeabilization 
of the plasma membrane. Pellets and cytosolic fractions were analyzed by Western blot analysis for cytochrome c levels. (F) Time course 
of caspase-3–like protease activity in SH-neo and SH-Bcl-xL cells after tunicamycin treatment. Cells were treated for the indicated times 
with 3  M tunicamycin, for 24 h with the vehicle DMSO (Con), or for 12 h with 0.1  M staurosporine (STS). Cytosolic protein extracts 
were prepared and their caspase-3–like protease activity was determined by measuring the cleavage of the fluorogenic substrate Ac-DEVD-
AMC (10  M). Data are means   SEM from n   4 separate experiments per time point. *, P   0.05, difference from vehicle-treated control 
(Con); #, P   0.05, difference from control cell line SH-neo.T
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shrinkage and chromatin condensation/fragmentation 16 h
after transfection (Fig. 7 A). In contrast, empty vector-trans-
fected controls remained morphologically largely intact.
Quantitative FACS
® analysis of propidium iodide of EGFP-
positive SH-SY5Y neuroblastoma cells transiently cotrans-
fected with expression plasmids encoding either HA-tagged
bbc3/PUMA (pHA-bbc3/PUMA), HA-tagged bbc3/PUMA
with a deletion in the BH3-domain (pHA-bbc3/PUMA-
 BH3), or empty vector (pcDNA3.1) demonstrated promi-
nent cell death in bbc3/PUMA-transfected cells, reduced
cell death in bbc3/PUMA- BH3–transfected cells (Han et
al., 2001), and little cell death in empty vector-transfected
cells (Fig. 7 B). Parallel Western blot analysis using an anti-
HA antibody showed comparable transfection rates in the
pHA-bbc3/PUMA– and pHA-bbc3/PUMA- BH3–trans-
fected cells (Fig. 7 B).
To investigate whether Bbc3/PUMA induction was re-
quired for ER stress–induced apoptosis in human cells,
we exposed HCT116 control cells and HCT116 cells
with targeted disruptions of both alleles of the bbc3/
PUMA gene (Yu et al., 2003) to the ER stressor thapsigar-
gin (1  M). Western blot analysis demonstrated a compa-
rable induction of the UPR target gene product BiP in
response to thapsigargin in control and Bbc3/PUMA-
deficient cells (Fig. 7 C). HCT116 control cells also showed
significant induction of Bbc3/PUMA protein in response
to thapsigargin. Interestingly, FACS
® analysis of DNA
content in HCT116 control and Bbc3/PUMA-deficient
cells exposed to thapsigargin demonstrated significantly
reduced apoptosis in the Bbc3/PUMA-deficient cells (Fig.
7, D and E), whereas the response to STS was not altered
(Fig. 7 E).
Figure 7. Expression of bbc3/PUMA 
may be sufficient and required for ER 
stress–induced apoptosis in human 
cells. (A) Transient transfection of SH-
SY5Y neuroblastoma cells with bbc3/
PUMA leads to induction of apoptosis. 
Cells were cotransfected with expression 
plasmids encoding enhanced GFP 
(pEGFP) and either a hemagglutinin-
tagged (HA) version of bbc3/PUMA (pHA-
PUMA) or empty vector (pcDNA3.1). 12 h 
after transfection, cells were fixed and 
stained with Hoechst 33258. Arrowheads 
point to transfected cells with the 
apoptotic phenotype. Similar results 
were obtained in a separate experiment. 
(B) Quantitative FACS
® analysis of PI 
uptake of EGFP-positive SH-SY5Y cells 
transiently cotransfected with expression 
vectors encoding hemagglutinin-tagged 
(HA) versions of Bbc3/PUMA, Bbc3/
PUMA- BH3, or empty vector 
(pcDNA3.1). Data were normalized 
to EGFP-only transfected controls and 
represent 10,000 events each. For 
evaluation of comparable transfection 
rates, whole-cell extracts of cells harvested 
16 h after transfection were analyzed by 
Western blotting. Blots were probed 
with an anti-hemagglutinin or anti-
 -tubulin antibody as loading control. 
(C) Protein levels of BiP, Bbc3/PUMA, 
and  -tubulin in human HCT116 control 
and Bbc3/PUMA-deficient cells treated 
with 1  M thapsigargin or vehicle for the 
indicated time points. (D) FACS
® analysis 
of sub-G1 cells of human HCT116 control 
and Bbc3/PUMA-deficient cells exposed 
to 1  M thapsigargin (TH) or vehicle for 
36 h. (E) Quantitative FACS
® analysis of 
thapsigargin- and STS (3  M)-induced 
apoptosis. Data from 10,000 events each 
are means   SEM from n   3 separate 
experiments per time point.T
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Discussion
ER stress response and protein quality control
In this analysis, we have used high density oligonucleotide
microarrays to analyze transcriptional changes during ER
stress–induced apoptosis in human SH-SY5Y neuroblas-
toma cells. Among the early and persistently induced genes,
we found genes that relieve ER stress by promoting protein
folding and by keeping proteins in a folding-competent
state. This group was represented by molecular chaperones
of the classical (BiP, GRP94) and nonclassical (lectin-like
molecular chaperones like calnexin and calreticulin) type,
along with protein disulfide isomerases. Also, we observed
the induction of the sarcoplasmic reticulum Ca
2 -ATPase 2
ATP2A2 (SERCA2) and the plasma membrane Ca
2  pump-
ing ATPase (ATP2B1). Up-regulation of SERCA2 has pre-
viously been observed in response to different ER stressors
(Hojmann Larsen et al., 2001). Up-regulation of both
plasma membrane- and ER-localized Ca
2 -ATPases may
help to relieve ER stress by refilling of ER Ca
2  stores.
A distinct group of genes differentially regulated by tuni-
camycin is involved in cotranslational translocation of pro-
teins across the ER membrane, protein trafficking to other
organelles such as mitochondria, and proteins involved in
retrograde transport back into the cytosol. With the excep-
tion of translocating chain–associating membrane protein,
this group of genes was induced late during ER stress. In-
duction of members of the SEC61 complex may link the
UPR with ER-associated degradation (ERAD; Wiertz et al.,
1996; Plemper et al., 1997). Hence, ER stress may result in
a highly ordered gene regulation process comprised of differ-
ent sequential steps: an early up-regulation of molecular
chaperones in order to keep nonglycosylated proteins in a
folding-competent state, followed by an improvement of the
capacity of the secretory pathway. If ER stress persists, the
ERAD pathway may be switched on to target unfolded pro-
teins to degradation via the proteasome.
Transcriptional regulation of ER stress
The transcription factor CHOP was the gene most strongly
induced by tunicamycin. In overexpression studies, CHOP
has been shown to negatively regulate cell cycle and induce
apoptosis (Barone et al., 1994; Zinszner et al., 1998). The
transcription factor C/EBP- , an interaction partner of
CHOP, was also strongly up-regulated during ER stress.
CHOP acts as a dominant-negative regulator of C/EBPs and
inhibits the DNA-binding activity of C/EBP-  by forming
heterodimers that cannot bind DNA (Ron and Habener,
1992). Therefore, CHOP may have a dual function; first
acting as an inhibitor of C/EBP proteins to activate distinct
target genes, and second, as a direct activator of CHOP tar-
get genes (Ubeda et al., 1996). Notably, we could not detect
increased expression of known “downstream of CHOP”
(doc) genes (Wang et al., 1998) such as homologues of the
actin-binding proteins villin and gelsolin and carbonic anhy-
drase VI (CA-VI). This suggests that CHOP does not func-
tion independently of other transcription factors (like
C/EBP- ) during ER stress, and favors the idea that tran-
scription is limited to genes activated by heterodimers of
CHOP-C/EBP- . We also observed the potent induction of
the transcription factor Egr-1, which was activated early and
transiently after ER stress. Egr-1 has been shown to be in-
duced as an “immediate-early gene” during several physio-
logical and pathophysiological stress conditions, including
ischemia (Yan et al., 2000). Egr-1 has previously been linked
to cell death induced by the ER Ca
2  ATPase inhibitor
thapsigargin, and has been shown to induce apoptosis in hu-
man melanoma cells (Muthukkumar et al., 1995).
ER stress and apoptosis
There are two possible outcomes of prolonged ER stress: (1)
an adaptive response promoting cell survival; or (2) the in-
duction of apoptotic cell death. Among the pro-apoptotic
genes, the BH3-only gene bbc3/PUMA was significantly
up-regulated after prolonged tunicamycin treatment. Bbc3/
PUMA was likewise up-regulated after an exposure to
thapsigargin, which induces ER stress by depleting ER Ca
2 
stores. bbc3/PUMA has previously been identified as a p53
target gene (Nakano and Vousden, 2001; Yu et al., 2001).
However, induction of bbc3/PUMA has also been shown to
involve p53-independent regulation (Han et al., 2001). Our
results demonstrate that the induction of bbc3/PUMA links
the cellular ER stress response to the mitochondrial apopto-
sis pathway, and that this may occur independently of p53.
Of note, human cells deficient in Bbc3/PUMA showed dra-
matically reduced apoptosis in response to ER stress. Inter-
estingly, they still maintained a very low level of apoptosis
(Fig. 7 E), suggesting that the (posttranslational) activation
of alternative BH3-only proteins or mitochondria-indepen-
dent apoptosis pathways may only partially compensate for a
Bbc3/PUMA deficiency. Induction of Bbc3/PUMA was also
observed in primary neuron cultures and in response to cere-
bral ischemia in vivo, suggesting that regulation of bbc3/
PUMA expression is a common pathway during ER stress–
induced cell death in mammals. Our finding that BH3-only
family members are also involved in apoptotic signaling
originating from the ER emphasizes the importance and di-
versity of this gene family in cellular life and death decisions.
Materials and methods
Materials
Tunicamycin, thapsigargin, etoposide, and STS were purchased from
Qbiogene. Caspase substrate acetyl-DEVD-7-amido-4-methylcoumarin
(Ac-DEVD-AMC) and the broad-spectrum caspase inhibitor Z-Val-
Ala-Asp(O-methyl)-fluoromethylketone (zVAD-fmk) were obtained from
Bachem. Hoechst 33258 was purchased from Sigma-Aldrich.
Cell lines, cell culture, and transfections
Human SH-SY5Y neuroblastoma cell lines were grown in RPMI 1640. The
generation of SH-SY5Y neuroblastoma cells stably overexpressing Bcl-xL
(SH-Bcl-xL) or stably transfected with the empty vector (SH-neo) has been
described previously (Luetjens et al., 2001). Human SAOS-2 osteosarcoma
cells completely lacking expression of endogenous p53 were grown in
DMEM culture medium. HCT116 control and Bbc3/PUMA knock-out cells
(provided by Drs. B. Vogelstein, L. Zhang, and J. Yu, Johns Hopkins On-
cology Center, Baltimore, MD) were maintained in McCoy’s 5A medium.
All media were supplemented with 10% (vol/vol) FCS, 100 U/ml penicil-
lin, and 100  g/ml streptomycin (Invitrogen). Primary cultures of hippo-
campal neurons were prepared from neonatal postnatal day 1 (P1) Fischer
344 rats as described previously (Luetjens et al., 2001). Experiments were
performed on 10- to 14-d-old cultures. Animal care followed official gov-
ernmental guidelines.
For transient transfections, SH-SY5Y cells were plated onto 6-well plates
(Nunc). 1 d later, cells were transfected with plasmids encoding HA-T
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tagged, full-length bbc3/PUMA expression vector (pHA-bbc3/PUMA), HA-
tagged, bbc3/PUMA expression vector with a deletion of the BH3 domain
(pHA-bbc3/PUMA- BH3; provided by Dr. B. Vogelstein), an expression
vector for eGFP (pEGFP-C1; CLONTECH Laboratories, Inc.), or empty vec-
tor (pcDNA3.1; Invitrogen) using LipofectAMINE™ transfection reagent
(Invitrogen). Transfection procedure was followed as described before
(Poppe et al., 2002).
Microarray analysis
SH-SY5Y neuroblastoma cells were treated with tunicamycin or vehicle
(0.1% DMSO), harvested, and total RNA was extracted using the RNeasy
Midi Kit (QIAGEN). cDNA was synthesized from 40  g of the total RNA by
using the SuperScript™ Choice Kit (Invitrogen). The cRNA was prepared
and biotin labeled by in vitro transcription (Enzo Biochemical). Labeled
cRNA was fragmented and hybridized for 16 h at 45 C to an HG-U95A ar-
ray (Affymetrix, Inc.). After hybridization, the gene chips were automati-
cally washed and stained with streptavidin-phycoerythrin by using a fluid-
ics station (GeneChip Fluidics Station 400; Affymetrix, Inc.). Finally, probe
arrays were scanned at a 3- m resolution using the Genechip System con-
focal scanner (Aligent Technologies). Microarray Suite 4.1 (Affymetrix, Inc.)
was used to scan and analyze the relative abundance of each gene from the
average difference of intensities. Analysis parameters used by the software
were set to values recommended by Affymetrix, Inc (SDT   4.0, SRT  
1.5). All chip data were normalized to a target intensity of 1000. For each
individual gene, the signal ratio between perfect match and mismatch
probe cells was used to determine its “Absolute Call,” indicating whether
the corresponding transcript was present (P), absent (A), or marginal (M).
For analysis of differential target gene expression, the “Difference Call De-
cision Matrix” was used. Individual transcript levels were ranked as either
increased (I), marginally increased (MI), decreased (D), marginally de-
creased (MD), or not changed (NC). To be considered as differentially regu-
lated, the Difference Call of individual transcripts had to be increased/de-
creased or marginally increased/marginally decreased at the respective time
point after treatment with tunicamycin, whereas the Absolute Call had to be
present or marginal at the respective time point (up-regulated genes) or in
the control (down-regulated genes). A list of all differentially regulated
genes meeting this criteria is provided in the online supplemental materials
(available at http://www.jcb.org/cgi/content/full/jcb.200305149/DC1). Genes
were also classified according to their expression kinetics. The highest fold-
induction in comparison to control was set to 100%. Genes up- and down-
regulated to at least 50% for all three time points were considered to be
persistently regulated. In all other cases, genes were ranked as early (4 h),
intermediate (8 h), or late (12 h), depending on the time point when the
maximal change of the corresponding transcript was reached. The output
from the microarray analysis was merged with the Unigene or GenBank de-
scriptor and stored as an Excel (Microsoft) data spreadsheet. For confirma-
tion of gene chip data, a replication experiment with a second set of inde-
pendent samples was performed, revealing similar results.
Digitonization
The release of cytochrome c from mitochondria was analyzed by a modi-
fied selective digitonin permeabilization method that was described previ-
ously (Wobser et al., 2002).
SDS-PAGE and Western blotting
Preparation of cell lysates, Western blotting, and immunodetection was
performed as described previously (Poppe et al., 2002). The blots were
incubated with a mouse monoclonal anti-BiP antibody (SPA 827; Stress-
Gen Biotechnologies) diluted 1:1,000, a mouse monoclonal anti-Bbc3 an-
tibody (KM140; Han et al., 2001) diluted 1:1,000, a rat monoclonal Bim
antibody (clone 14A8; Qbiogene) diluted 1:1,000, a rabbit polyclonal Bid an-
tibody (#2315-PC; Trevigen) diluted 1:1,000, a rabbit polyclonal p53
antibody (NCL-p53-CM1; Loxo) diluted 1:1,000, a mouse monoclonal
p21/WAF antibody (Ab-4, #OP 76; Oncogene Research Products) diluted
1:500, a mouse monoclonal cytochrome c antibody (clone 7H8.2C12;
BD Biosciences) diluted 1:1,000, a rabbit polyclonal anti-caspase-3 anti-
body (H-277; Santa Cruz Biotechnology, Inc.) diluted 1:1,000, a rabbit
polyclonal anti-caspase-9 antibody (#556585; BD Biosciences) diluted
1:1,000, a mouse monoclonal anti-hemagglutinin (HA) antibody (12CA5;
Roche) diluted 1:1,000, or a mouse monoclonal anti- -tubulin antibody
(DM 1A; Sigma-Aldrich), diluted 1:20,000.
RT-PCR
Validation of up-regulated target gene expression was performed by RT-
PCR analysis for selected genes. We designed unique oligonucleotide
primer pairs by using PRIMER3 software (www.genome.wi.mit.edu/cgi-
bin/primer/primer3_www.cgi). Primer sequences are available on request
from the authors. Total RNA, purified from tunicamycin-treated cells using
the RNeasy Mini kit (QIAGEN), was subjected to RT-PCR in a two-step
protocol using M-MLV reverse transcriptase (Invitrogen) and Taq polymer-
ase (Eppendorf; Kögel et al., 2003). The number of cycles and annealing
temperature was adjusted depending on the genes amplified.
Northern blot analysis
Total RNA was isolated using the RNeasy Mini or Midi Kit (QIAGEN). 10
 g RNA was subjected to gel electrophoresis on 1.1% formaldehyde/1.2%
agarose gels and transferred to nylon membranes (Amersham Biosciences).
After UV cross-linking and prehybridization in 50% formamide, 5  SSC,
5  Denhardt’s solution, and 1% SDS, pH 7.4, at 65 C for 30 min, the blots
were hybridized with an  [
32P]dCTP-labeled full-length human bbc3/
PUMA cDNA probe (Han et al., 2001) and a 700-bp fragment of human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in 50% formamide,
5  SSC, 5  Denhardt’s solution, and 1% SDS, pH 7.4, at 47 C, and were
washed according to standard procedures. Membranes were exposed to
X-ray film for 24 to 72 h.
Flow cytometry analysis
The measurement of propidium iodide uptake and DNA leakage from apop-
totic nuclei and was performed as described previously (Poppe et al., 2002).
Determination of caspase-3–like protease activity
Caspase-3–like protease activity of cells exposed to tunicamycin or vehicle
was determined as described before (Poppe et al., 2002).
Transient forebrain ischemia
Transient forebrain ischemia was performed in male Wistar rats (250–300 g;
Smith et al., 1984). Cerebral ischemia was induced by clamping both
common carotid arteries and lowering the mean arterial blood pressure
to 40 mm Hg. After 10 min ischemia, the blood pressure was restored by
re-infusion of blood and removal of the clamps. Arterial pH, pCO2, pO2,
arterial blood pressure, and plasma glucose concentration were deter-
mined 15 min before and 15 min after the induction of ischemia. Sham-
operated rats served as controls. Animal care followed official govern-
mental guidelines.
Immunohistochemistry
At different time points after cerebral ischemia, rats were anaesthetized
with 3.5% halothane and perfused transcardially with phosphate buffer
(pH 7.4) containing 4% formaldehyde. The sections were deparaffinized,
washed, and subjected to histochemical analysis as described previously
(Rami et al., 2000). Sections were incubated with an mAb against CHOP
(sc-7351, Santa Cruz Biotechnology, Inc.) diluted 1:10, or a pAb against
Bbc3/PUMA (provided by Dr. Karen Vousden (Beatson Institute for Can-
cer Research, Glasgow, UK; Nakano and Vousden, 2001) diluted 1:50
overnight at 4 C. The immunoreaction was developed with 3,3 -DAB tet-
rahydrochloride and hydrogen peroxide. Sections were counterstained
with cresyl violet.
Immunofluorescence analysis and Hoechst staining
Tunicamycin-treated cells were washed, fixed with 4% PFA, and perme-
abilized. A rabbit polyclonal anti-Bax antibody specifically recognizing
active Bax (Desagher et al., 1999; #06–499, Upstate Biotechnology) di-
luted 1:500, the KM140 mouse monoclonal antibody specific for Bbc3 di-
luted 1:50, or a mouse monoclonal anti-cytochrome c antibody (clone
6H2.B4, #65971; BD Biosciences) diluted 1:1,000 were used to detect
the respective proteins. After washing, biotin-conjugated anti–mouse or
anti–rabbit IgG (1:1,000; Vector Laboratories) was added for 1 h, followed
by a 20 min treatment with streptavidin-Oregon green conjugate (1  g/ml;
Molecular Probes, Inc.). In case of the cytochrome c staining, a Texas
red–coupled anti–mouse antibody was used (T-0300; Molecular Probes,
Inc.). As a negative control, cultures were incubated with the secondary
antibody only. Fluorescence was observed using an inverted microscope
(Eclipse TE300; Nikon). Digital images of equal exposure were acquired
with the SPOT-2 camera using SPOT software version 2.2.1 (Diagnostic
Instruments). Nuclei were stained with Hoechst 33258 (1  g/ml in PBS)
for 20 min.
Statistics
Data are given as means   SEM. For statistical comparison, t test or one-
way ANOVA followed by Tukey test were used. P values smaller than 0.05
were considered to be statistically significant.T
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Online supplemental material
Supplemental material lists 711 genes that showed differential expression
during tunicamycin-induced ER stress analyzed using Affymetrix, Inc.
U95A microarrays and Microarray Suite 4.1 software. For each gene, the
probe set number, the absolute call (P, present; M, marginal), difference
call (D, decrease; I, increase; MD, marginal decrease; MI, marginal in-
crease), the fold change value, and the description containing the acces-
sion no. are shown. Online supplemental material available at http://
www.jcb.org/cgi/content/full/jcb.200305149/DC1.
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